We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pipeline cherrypicking deal yields lucrative return.
- Authors
Ransom, John
- Abstract
The article reports about the success of Exelixis Inc., a biotechnology company based in San Francisco, California. The company has been successful in getting small molecules into clinical trials. It has presented phase one clinical trial data for three kinase inhibitors in line with its partnership with GlaxoSmithKline at the 2006 American Society of Clinical Oncology annual meeting held in Atlanta, Georgia June 2-3, 2006. Exelixis stands as a model for the drug development in biotechnology.
- Subjects
SAN Francisco (Calif.); CALIFORNIA; EXELIXIS Inc.; BIOTECHNOLOGY; CLINICAL medicine; CLINICAL trials
- Publication
Nature Biotechnology, 2006, Vol 24, Issue 7, p729
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0706-729